Rubin P - Search Results

1

Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.

Weinblatt ME, Kremer JM, Coblyn JS, Helfgott S, Maier AL, Petrillo G, Henson B, Rubin P, Sperling R. Weinblatt ME, et al. Among authors: rubin p. J Rheumatol. 1992 Oct;19(10):1537-41. J Rheumatol. 1992. PMID: 1334515 Clinical Trial.

2

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air.

Israel E, Dermarkarian R, Rosenberg M, Sperling R, Taylor G, Rubin P, Drazen JM. Israel E, et al. Among authors: rubin p. N Engl J Med. 1990 Dec 20;323(25):1740-4. doi: 10.1056/NEJM199012203232505. N Engl J Med. 1990. PMID: 2247106 Free article. Clinical Trial.

3

Role of cysteinyl leukotrienes in spontaneous asthmatic responses.

Drazen JM, Lilly CM, Sperling R, Rubin P, Israel E. Drazen JM, et al. Among authors: rubin p. Adv Prostaglandin Thromboxane Leukot Res. 1994;22:251-62. Adv Prostaglandin Thromboxane Leukot Res. 1994. PMID: 7771339 Review. No abstract available.

4

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma.

Israel E, Rubin P, Kemp JP, Grossman J, Pierson W, Siegel SC, Tinkelman D, Murray JJ, Busse W, Segal AT, Fish J, Kaiser HB, Ledford D, Wenzel S, Rosenthal R, Cohn J, Lanni C, Pearlman H, Karahalios P, Drazen JM. Israel E, et al. Among authors: rubin p. Ann Intern Med. 1993 Dec 1;119(11):1059-66. doi: 10.7326/0003-4819-119-11-199312010-00001. Ann Intern Med. 1993. PMID: 8239223 Clinical Trial.

5

The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.

Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Shapiro J, Cohn J, Rubin P, Drazen JM. Israel E, et al. Among authors: rubin p. Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1447-51. doi: 10.1164/ajrccm/148.6_Pt_1.1447. Am Rev Respir Dis. 1993. PMID: 8256883 Clinical Trial.

6

Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo.

Sirois P, Borgeat P, Lauzière M, Dubé L, Rubin P, Kesterson J. Sirois P, et al. Among authors: rubin p. Agents Actions. 1991 Sep;34(1-2):117-20. doi: 10.1007/BF01993254. Agents Actions. 1991. PMID: 1665285 Clinical Trial.

7

The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.

Bell RL, Young PR, Albert D, Lanni C, Summers JB, Brooks DW, Rubin P, Carter GW. Bell RL, et al. Among authors: rubin p. Int J Immunopharmacol. 1992 Apr;14(3):505-10. doi: 10.1016/0192-0561(92)90182-k. Int J Immunopharmacol. 1992. PMID: 1618602 Review.

8

Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.

Rubin P, Dubé L, Braeckman R, Swanson L, Hansen R, Albert D, Carter G. Rubin P, et al. Agents Actions Suppl. 1991;35:103-16. Agents Actions Suppl. 1991. PMID: 1781415 Clinical Trial.

9

Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma.

Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, White MV, Igarashi Y, Kaliner MA, Drazen JM, et al. Fischer AR, et al. Among authors: rubin p. J Allergy Clin Immunol. 1994 Dec;94(6 Pt 1):1046-56. doi: 10.1016/0091-6749(94)90123-6. J Allergy Clin Immunol. 1994. PMID: 7798537 Clinical Trial.

10

Preclinical and clinical activity of zileuton and A-78773.

Bell RL, Lanni C, Malo PE, Brooks DW, Stewart AO, Hansen R, Rubin P, Carter GW. Bell RL, et al. Among authors: rubin p. Ann N Y Acad Sci. 1993 Nov 30;696:205-15. doi: 10.1111/j.1749-6632.1993.tb17153.x. Ann N Y Acad Sci. 1993. PMID: 8109828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,076 results

Search Page